Two‐year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double‐blind, placebo‐controlled extension trial

Objective To evaluate the continued efficacy and safety of alendronate (ALN) for up to 2 years in patients receiving glucocorticoids. Methods This is a 12‐month extension of a previously completed 1‐year trial of daily ALN, performed to evaluate the effects of ALN over a total of 2 years in 66 men a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arthritis and rheumatism 2001-01, Vol.44 (1), p.202-211
Hauptverfasser: Adachi, Jonathan D., Saag, Kenneth G., Delmas, Pierre D., Liberman, Uri A., Emkey, Ronald D., Seeman, Ego, Lane, Nancy E., Kaufman, Jean‐Marc, Poubelle, Patrice E. E., Hawkins, Federico, Correa‐Rotter, Ricardo, Menkes, Charles‐Joel, Rodriguez‐Portales, Jose A., Schnitzer, Thomas J., Block, Joel A., Wing, Jeffrey, McIlwain, Harris H., Westhovens, Rene, Brown, Jacques, Melo‐Gomes, Jose A., Gruber, Barry L., Yanover, Melissa J., Leite, Maria Odette R., Siminoski, Kerry G., Nevitt, Michael C., Sharp, John T., Malice, Marie‐Pierre, Dumortier, Thomas, Czachur, Michelle, Carofano, Wendy, Daifotis, Anastasia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!